Literature DB >> 8194201

An anti-invasive concentration of the alkyl-lysophospholipid ET-18-OCH3 enhances the motility of embryonal chick heart cells cultured on solid substrate.

N A van Larebeke1, E A Bruyneel, M M Mareel.   

Abstract

Pretreatment of embryonal chick heart fragments with ET-18-OCH3 is known to induce resistance to invasion by several malignant cell lines. Embryonal chick heart fragments or cell suspensions prepared from such fragments were explanted on solid substrate and treated in medium with 10 micrograms/ml ET-18-OCH3 or with drug-free medium (control) for 48 h. This medium was washed away and replaced by drug-free fresh medium. Twenty-four to 48 h later the fast plasma membrane movements (involved in ruffling, blebbing, fast shape change and fast translocation) were quantified using a simple method based on subtracting two video images taken with an interval of 28 s. The ET-18-OCH3-treated cells showed a higher intensity of fast plasma membrane movements than control cells. Cells around a treated explant did not show the same radial alignment as in controls, suggesting loss of contact inhibition of movement. Cells from a cell suspension derived from a treated fragment showed faster translocation on solid substrate and faster shape change. We speculate that increased motility of host cells may be involved in resistance to invasion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8194201     DOI: 10.1007/bf01753894

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  27 in total

1.  High invasiveness associated with augmentation of motility in a fos-transferred highly metastatic rat 3Y1 cell line.

Authors:  S Taniguchi; M Tatsuka; K Nakamatsu; M Inoue; H Sadano; H Okazaki; H Iwamoto; T Baba
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

2.  Developmental regulation of ganglioside antigens recognized by the JONES antibody.

Authors:  B Schlosshauer; A S Blum; R Mendez-Otero; C J Barnstable; M Constantine-Paton
Journal:  J Neurosci       Date:  1988-02       Impact factor: 6.167

3.  Modification of cell surface carbohydrates and invasive behavior by an alkyl lysophospholipid.

Authors:  J G Bolscher; D C Schallier; H van Rooy; G A Storme; L A Smets
Journal:  Cancer Res       Date:  1988-02-15       Impact factor: 12.701

4.  Fourier analysis of cell motility: correlation of motility with metastatic potential.

Authors:  A W Partin; J S Schoeniger; J L Mohler; D S Coffey
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  Methods of study of the invasion of malignant C3H-mouse fibroblasts into embryonic chick heart in vitro.

Authors:  M Mareel; J Kint; C Meyvisch
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1979-05-04

6.  Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with the v-Harvey-ras oncogene.

Authors:  A W Partin; J T Isaacs; B Treiger; D S Coffey
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

7.  Effect of lipid derivatives on invasion in vitro and on surface glycoproteins of three rodent cell types.

Authors:  G A Storme; E A Bruyneel; D C Schallier; J G Bolscher; W E Berdel; M M Mareel
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

8.  Distribution and metabolism of synthetic alkyl analogs of lysophosphatidylcholine in mice.

Authors:  B Arnold; R Reuther; H U Weltzien
Journal:  Biochim Biophys Acta       Date:  1978-07-25

9.  Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro.

Authors:  G A Storme; W E Berdel; W J van Blitterswijk; E A Bruyneel; G K De Bruyne; M M Mareel
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

10.  Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model.

Authors:  J L Mohler; A W Partin; J T Isaacs; D S Coffey
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.